Assignee
CENTIVAX INC
US·9 granted patents·6 pending applications·59 citations·filing 2020–2025
Top patents by PatentIndex Score
15 records- 0193US11028167B1Anti-SARS-Cov-2 antibodies derived from 3bgfCENTIVAX INC·Filed 2020·Granted Jun 8, 2021·11 cites·21 claims
- 0293US11021531B1Anti-SARS-Cov-2 antibodies derived from 2GHWCENTIVAX INC·Filed 2020·Granted Jun 1, 2021·17 cites·16 claims
- 0392US11053304B1Anti-SARS-Cov-2 antibodies derived from 6nb6CENTIVAX INC·Filed 2020·Granted Jul 6, 2021·10 cites·21 claims
- 0492US11028150B1Anti-SARS-CoV-2 antibodies derived from 2DD8CENTIVAX INC·Filed 2020·Granted Jun 8, 2021·7 cites·21 claims
- 0592US11021532B1Superhuman anti-SARS-CoV-2 antibodies and uses thereofCENTIVAX INC·Filed 2020·Granted Jun 1, 2021·9 cites·17 claims
- 0691US11034762B1Anti-SARS-Cov-2 antibodies derived from CR3022CENTIVAX INC·Filed 2020·Granted Jun 15, 2021·4 cites·13 claims
- 0790US2025145668A1Epitope focusing by variable effective antigen surface concentrationCENTIVAX INC·Filed 2024·Application pending·0 cites
- 0886US11560409B2Epitope focusing by variable effective antigen surface concentrationCENTIVAX INC·Filed 2020·Granted Jan 24, 2023·1 cites·22 claims
- 0984US12043647B2Epitope focusing by variable effective antigen surface concentrationCENTIVAX INC·Filed 2022·Granted Jul 23, 2024·0 cites·15 claims
- 1065US2026097112A1Vaccine compositions and uses thereofCENTIVAX INC·Filed 2025·Application pending·0 cites
- 1163US2024294618A1Anti-venom antibodies and uses thereofCENTIVAX INC·Filed 2023·Application pending·0 cites
- 1261US2024270825A1Anti-sars-cov-2 antibodies derived from cr3022CENTIVAX INC·Filed 2023·Application pending·0 cites
- 1358US12534513B2Anti-SARS-CoV-2 antibodies derived from 2DD8CENTIVAX INC·Filed 2022·Granted Jan 27, 2026·0 cites·1 claims
- 1455US2026027196A1Low dose vaccine compositionsCENTIVAX INC·Filed 2025·Application pending·0 cites
- 1549US2022088175A1Optimized vaccine compositions and methods for making the sameCENTIVAX INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →